Eda Yildiz1 , Duha Zaffar2 , N. Begum Ozturk3 , Merve Gurakar1 , A. Eylul Donmez1 , Merih Deniz Toruner4 , Cem Simsek1 , Ahmet Gurakar 1 2Department of Internal Medicine, University of Maryland Midtown Campus, Baltimore, Maryland, USA
3Department of Internal Medicine, Beaumont Hospital, Royal Oak, Michigan, USA
4Brown University Warren Alpert, School of Medicine School, Providence, Rhode Island, USA
Abstract
Alcoholic liver disease(ALD) is considered as a growing public health issue with universally increasing disease burden. Various genetic and environmental factors play role in its etiology. ALD recently has become the major indication for Liver Transplantation (LT). Most LT programs select their candidates by adhering to six months of alcohol abstinence policy. Nevertheless, early liver transplantation (ELT) has become a subject of research, both in Europe and the United States, as an effective and lifesaving option among highly selected severe alcohol-associated hepatitis (SAH) patients. ELT is a promising way in the management of ALD, perhaps changing clinical practice for carefully selected patient groups.
